Vasant Narasimhan

Global Head, Drug Development; Chief Executive Officer-designate, Novartis AG

Bachelor's in Biological Sciences, University of Chicago; MD, Harvard Medical School; Master's in Public Policy, John F. Kennedy School of Government, Harvard. Formerly: with McKinsey & Company. 2005, joined Novartis: held commercial and strategic roles; former Region Head, Novartis Vaccines North America and US Country President, Novartis Vaccines and Diagnostics; has held numerous leadership positions in the development and commercial functions; also served as Global Development Head, Novartis Vaccines; led the Sandoz biosimilars and oncology injectables business unit, overseeing the Sandoz biosimilars pipeline; since 2014, Global Head, Development, Novartis Pharmaceuticals; since 2016, Global Head, Drug Development and Chief Medical Officer; Member of the Executive Committee. Elected Member, US National Academy of Medicine.